Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deltix is a software company that provides high-performance software and services for quantitative research, algorithmic trading, and real-time event processing. While primarily known for its presence in the capital markets and fintech sectors, the company's technology is utilized for complex data analysis and predictive modeling. In 2020, Deltix was acquired by EPAM Systems, a global provider of digital platform engineering and software development services. Following the acquisition, Deltix's quantitative analysis capabilities have been integrated into EPAM's broader offerings, which include significant data science and engineering support for the life sciences and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deltix.